My Approach

Building clarity that secures access.

Dr. Schaufler Access Advisory delivers strategic clarity that secures sustainable reimbursement and patient access. By co-creating strategy, integrated evidence plans, and compelling value propositions, I help Market Access leaders and their teams strengthen both strategic and leadership capabilities.

Smaller and mid-sized biopharma companies, in particular, face increasing complexity — from regulatory evolution like the EU HTAR to growing expectations for data-driven decision-making. My approach is designed to bring focus, confidence, and credibility where they matter most.

Building Clarity

Every successful access strategy begins with clarity — on what truly drives value for patients, payers, and organisations. Together, we define the right problem to solve, distill evidence into insight, and align internal stakeholders around a shared purpose.

This analytical foundation ensures that every subsequent discussion — internal or external — stands on solid ground.

Co-Creating Solutions

Strategy ownership matters — but no leader should have to do it alone. I work directly with clients as a strategic peer, pressure-testing assumptions, shaping options, and co-creating implementable solutions that connect evidence, policy, and payer perspectives.

Rather than producing generic slide decks, this collaboration delivers tailored frameworks and practical roadmaps that drive decision-making and confidence.

Networked Model

No two challenges are identical. When specialised expertise is needed — in regulatory, commercial, or data analytics domains — I connect clients with a trusted network of senior partners who share the same commitment to clarity and collaboration.

This model keeps engagements lean, senior, and outcome-focused — providing flexibility and speed without the overhead of large consultancies.